Clinical Trial Update: Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct [Phase 2]

View source ↗

Summary

Phase 2 study evaluating imatinib in combination with 5-FU/leucovorin for advanced gallbladder cancer and biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• 5-FU/leucovorin (5-fluorouracil/leucovorin)
• Imatinib (imatinib)

Snippet

Sponsor: University Hospital Dresden | Conditions: Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct | Phase 2 | Status: COMPLETED